Literature DB >> 2573997

Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

J T Den Dunnen1, P M Grootscholten, E Bakker, L A Blonden, H B Ginjaar, M C Wapenaar, H M van Paassen, C van Broeckhoven, P L Pearson, G J van Ommen.   

Abstract

We have studied 34 Becker and 160 Duchenne muscular dystrophy (DMD) patients with the dystrophin cDNA, using conventional blots and FIGE analysis. One hundred twenty-eight mutations (65%) were found, 115 deletions and 13 duplications, of which 106 deletions and 11 duplications could be precisely mapped in relation to both the mRNA and the major and minor mutation hot spots. Junction fragments, ideal markers for carrier detection, were found in 23 (17%) of the 128 cases. We identified eight new cDNA RFLPs within the DMD gene. With the use of cDNA probes we have completed the long-range map of the DMD gene, by the identification of a 680-kb SfiI fragment containing the gene's 3' end. The size of the DMD gene is now determined to be about 2.3 million basepairs. The combination of cDNA hybridizations with long-range analysis of deletion and duplication patients yields a global picture of the exon spacing within the dystrophin gene. The gene shows a large variability of intron size, ranging from only a few kilobases to 160-180 kb for the P20 intron.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573997      PMCID: PMC1683480     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  41 in total

1.  Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations.

Authors:  B T Darras; P Blattner; J F Harper; A J Spiro; S Alter; U Francke
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

2.  The DMD gene analysed by field inversion gel electrophoresis.

Authors:  J T den Dunnen; E Bakker; G J van Ommen; P L Pearson
Journal:  Br Med Bull       Date:  1989-07       Impact factor: 4.291

3.  Mapping of Xp21 translocation breakpoints in and around the DMD gene by pulsed field gel electrophoresis.

Authors:  T Meitinger; Y Boyd; R Anand; I W Craig
Journal:  Genomics       Date:  1988-11       Impact factor: 5.736

4.  Duchenne muscular dystrophy gene product is not identical in muscle and brain.

Authors:  U Nudel; D Zuk; P Einat; E Zeelon; Z Levy; S Neuman; D Yaffe
Journal:  Nature       Date:  1989-01-05       Impact factor: 49.962

Review 5.  Prenatal diagnosis of Duchenne muscular dystrophy: a three-year experience in a rapidly evolving field.

Authors:  E Bakker; E J Bonten; H Veenema; J T den Dunnen; P M Grootscholten; G J van Ommen; P L Pearson
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy.

Authors:  E Bonilla; B Schmidt; C E Samitt; A F Miranda; A P Hays; A B de Oliveira; H W Chang; S Servidei; E Ricci; D S Younger
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

7.  Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia.

Authors:  E R McCabe; J Towbin; J Chamberlain; L Baumbach; J Witkowski; G J van Ommen; M Koenig; L M Kunkel; W K Seltzer
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

8.  High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization.

Authors:  L A Blonden; J T den Dunnen; H M van Paassen; M C Wapenaar; P M Grootscholten; H B Ginjaar; E Bakker; P L Pearson; G J van Ommen
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

9.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

10.  Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

Authors:  J S Chamberlain; R A Gibbs; J E Ranier; P N Nguyen; C T Caskey
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more
  145 in total

1.  Identification and quantification of somatic mosaicism for a point mutation in a Duchenne muscular dystrophy family.

Authors:  T A Smith; S C Yau; M Bobrow; S J Abbs
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

2.  Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications.

Authors:  Y Hiraishi; S Kato; T Ishihara; T Takano
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

Review 3.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

4.  Screening Duchenne and Becker muscular dystrophy patients for deletions in 30 exons of the dystrophin gene by three-multiplex PCR.

Authors:  A E Covone; F Caroli; G Romeo
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

5.  Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene.

Authors:  C Dehainault; A Laugé; V Caux-Moncoutier; S Pagès-Berhouet; F Doz; L Desjardins; J Couturier; M Gauthier-Villars; D Stoppa-Lyonnet; C Houdayer
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

6.  Direct analysis of amniotic fluid cells by multiplex PCR provides rapid prenatal diagnosis for Duchenne muscular dystrophy.

Authors:  L R Simard; F Gingras; D Labuda
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

7.  Screening of gene deletions by polymerase chain reaction in Japanese patients with Duchenne muscular dystrophy.

Authors:  T Nakajima; M Matsuo; Y Kitoh; T Takumi; H Nishio; T Masumura; J Koga; H Nakamura
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

8.  Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.

Authors:  Annemieke Aartsma-Rus; Anneke A M Janson; Wendy E Kaman; Mattie Bremmer-Bout; Gert-Jan B van Ommen; Johan T den Dunnen; Judith C T van Deutekom
Journal:  Am J Hum Genet       Date:  2003-12-16       Impact factor: 11.025

9.  Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.

Authors:  Pawandeep Dhami; Alison J Coffey; Stephen Abbs; Joris R Vermeesch; Jan P Dumanski; Karen J Woodward; Robert M Andrews; Cordelia Langford; David Vetrie
Journal:  Am J Hum Genet       Date:  2005-03-08       Impact factor: 11.025

10.  Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene.

Authors:  Linda J Popplewell; Capucine Trollet; George Dickson; Ian R Graham
Journal:  Mol Ther       Date:  2009-01-13       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.